Prevented

Oncology/Hematology > Hemophilia — No factor VIII inhibitors developed among the 74 boys included in the study by Mike Bassett, Staff Writer, MedPage Today July 17, 2024 Once-weekly prophylaxis with efanesoctocog alfa (Altuviiio) led to high sustained factor VIII activity and was effective in preventing bleeding among children with severe hemophilia A, the phase III